According to the AUGUSTUS Trial Apixaban (Eliquis ® ) was Found to Be Safer than Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation with Acute Coronary Syndrome and/or Percutaneous Coronary Intervention

According to the AUGUSTUS Trial Apixaban (Eliquis ® ) was Found to Be Safer than Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation with Acute Coronary Syndrome and/or Percutaneous Coronary Intervention

Show other versions (1)

Pfizer Company Press Release.

Bibliographic Details
Main Author: Company Pfizer
Format: Article
Language:English
Published: Столичная издательская компания 2019-09-01
Series:Рациональная фармакотерапия в кардиологии
Online Access:https://www.rpcardio.com/jour/article/view/2015

Similar Items

Similar Items